We are live on ! Find out more
CA

CoreCap Advisors Portfolio holdings

AUM $3.39B
1-Year Est. Return 31.21%
This Fund
S&P 500
This Quarter Est. Return
-2.01%
1 Year Est. Return
+31.21%
3 Year Est. Return
+83.55%
5 Year Est. Return
10 Year Est. Return
AUM
$2.27B
AUM Growth
+$74.9M
Cap. Flow
+$141M
Cap. Flow %
6.2%
Top 10 Hldgs %
27.91%
Holding
3,353
New
505
Increased
1,069
Reduced
882
Closed
214

Sector Composition

Rank Sector Weight
1 Miscellaneous 76.36%
2 Technology 6.11%
3 Financials 3.37%
4 Consumer Discretionary 2.8%
5 Consumer Staples 2.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNAM
2726
DELISTED
Avidity Biosciences
RNAM
$443 ﹤0.01%
15
THM
2727
International Tower Hill Mines
THM
$636M
$442 ﹤0.01%
700
AGO icon
2728
Assured Guaranty
AGO
$3.13B
$440 ﹤0.01%
+5
New +$448
RSI icon
2729
Rush Street Interactive
RSI
$2.92B
$440 ﹤0.01%
+41
New +$539
TNGX icon
2730
Tango Therapeutics
TNGX
$3.96B
$440 ﹤0.01%
321
-427
-57% -$1.05K
BLUE
2731
DELISTED
bluebird bio
BLUE
$439 ﹤0.01%
+90
New +$541
MBI icon
2732
MBIA
MBI
$231M
$438 ﹤0.01%
88
+9
+11% +$56
LEVI icon
2733
Levi Strauss
LEVI
$7.64B
$437 ﹤0.01%
28
BUR icon
2734
Burford Capital
BUR
$876M
$436 ﹤0.01%
33
JELD icon
2735
JELD-WEN Holding
JELD
$164M
$436 ﹤0.01%
73
LIND icon
2736
Lindblad Expeditions
LIND
$1.82B
$436 ﹤0.01%
+47
New +$536
LITE icon
2737
Lumentum
LITE
$80.2B
$436 ﹤0.01%
7
-390
-98% -$30K
SABA
2738
Saba Capital Income & Opportunities Fund II
SABA
$217M
$435 ﹤0.01%
50
-1,000
-95% -$9.01K
PBI icon
2739
Pitney Bowes
PBI
$2.37B
$434 ﹤0.01%
48
TRDA icon
2740
Entrada Therapeutics
TRDA
$269M
$434 ﹤0.01%
+48
New +$598
DAVA icon
2741
Endava
DAVA
$155M
$429 ﹤0.01%
22
LOB icon
2742
Live Oak Bancshares
LOB
$1.77B
$427 ﹤0.01%
+16
New +$532
THRD
2743
DELISTED
Third Harmonic Bio
THRD
$427 ﹤0.01%
+123
New +$596
PRG icon
2744
PROG Holdings
PRG
$1.42B
$426 ﹤0.01%
+16
New +$565
VIAV icon
2745
Viavi Solutions
VIAV
$8.57B
$425 ﹤0.01%
38
JBLU icon
2746
JetBlue
JBLU
$1.68B
$419 ﹤0.01%
87
-43
-33% -$283
CNH
2747
CNH Industrial
CNH
$21.8B
$418 ﹤0.01%
34
-133
-80% -$1.67K
NUVB icon
2748
Nuvation Bio
NUVB
$2.13B
$417 ﹤0.01%
+237
New +$539
OLPX
2749
DELISTED
Olaplex Holdings
OLPX
$408 ﹤0.01%
+321
New +$475
CMPR icon
2750
Cimpress
CMPR
$1.98B
$407 ﹤0.01%
9
+1
+13% +$56

Similar funds

CoreCap Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, CoreCap Advisors held 3,353 positions worth $2.27B, up 3.4% from $2.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

CoreCap Advisors deployed $141M of net new capital in Q1 2025, opening 505 new positions and adding to 1,069 existing holdings. Its largest new stake was Goldman Sachs Equal Weight US Large Cap Equity ETF: 119,971 shares worth $9.12M.

By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, up from 75% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Invesco NASDAQ 100 ETF, an estimated $12.4M trimmed.

  • CoreCap Advisors's largest Q1 2025 buy was Goldman Sachs Equal Weight US Large Cap Equity ETF: 119,971 shares worth $9.12M.
  • CoreCap Advisors added most to Invesco QQQ Trust in Q1 2025, an estimated $23M increase.
  • CoreCap Advisors's biggest Q1 2025 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $12.4M.
  • CoreCap Advisors fully exited Lloyds Banking Group in Q1 2025, selling an estimated $2.07M.
  • CoreCap Advisors's ten largest holdings make up 28% of its $2.27B portfolio in Q1 2025.
  • CoreCap Advisors opened 505 new positions and closed 214 in Q1 2025.
  • CoreCap Advisors's portfolio value rose 3.4% quarter-over-quarter to $2.27B.

Based on CoreCap Advisors's 13F filing for Q1 2025, filed 9 May 2025.